Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 7
2003 9
2004 10
2005 10
2006 10
2007 10
2008 14
2009 18
2010 12
2011 8
2012 6
2013 5
2014 10
2015 4
2016 6
2017 7
2018 3
2019 5
2020 2
2021 4
2022 5
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

144 results

Results by year

Filters applied: . Clear all
Page 1
Response to the Editor.
Ohta H, Uenishi K, Shiraki M. Ohta H, et al. Osteoporos Sarcopenia. 2017 Mar;3(1):60-61. doi: 10.1016/j.afos.2017.01.004. Epub 2017 Feb 23. Osteoporos Sarcopenia. 2017. PMID: 30775505 Free PMC article. No abstract available.
[Prevention of osteoporosis].
Ohta H. Ohta H. Clin Calcium. 2012 Jun;22(6):825-31. Clin Calcium. 2012. PMID: 22653020 Review. Japanese.
Reliability of early stage symptoms/clinical findings of osteonecrosis of the jaw: Japanese Osteoporosis Intervention Trial-05 (JOINT-05).
Taguchi A, Tanaka S, Ozaki T, Arai K, Mori S, Ohta H, Hagino H, Tanaka S, Shiraki M, Nakamura T, Soen S; Adequate Treatment of Osteoporosis (A-TOP) Research Group. Taguchi A, et al. Among authors: ohta h. J Bone Miner Metab. 2023 Nov;41(6):854-864. doi: 10.1007/s00774-023-01466-3. Epub 2023 Oct 28. J Bone Miner Metab. 2023. PMID: 37897672 Clinical Trial.
Evaluation of the efficacy of Lactobacillus-containing feminine hygiene products on vaginal microbiome and genitourinary symptoms in pre- and postmenopausal women: A pilot randomized controlled trial.
Yoshikata R, Yamaguchi M, Mase Y, Tatsuyuki A, Myint KZY, Ohta H. Yoshikata R, et al. Among authors: ohta h. PLoS One. 2022 Dec 30;17(12):e0270242. doi: 10.1371/journal.pone.0270242. eCollection 2022. PLoS One. 2022. PMID: 36584204 Free PMC article. Clinical Trial.
Effect of Bone Resorption Inhibitors on Serum Cholesterol Level and Fracture Risk in Osteoporosis: Randomized Comparative Study Between Minodronic Acid and Raloxifene.
Ohta H, Uemura Y, Sone T, Tanaka S, Soen S, Mori S, Hagino H, Fukunaga M, Nakamura T, Orimo H, Shiraki M; Adequate Treatment of Osteoporosis (A-TOP) research group. Ohta H, et al. Calcif Tissue Int. 2023 Apr;112(4):430-439. doi: 10.1007/s00223-023-01060-9. Epub 2023 Jan 28. Calcif Tissue Int. 2023. PMID: 36707436 Free PMC article. Clinical Trial.
[A-TOP research group/JOINT-02].
Kuroda T, Ohta H, Shiraki M, Miyakawa N, Hosoi T, Nakamura T, Fukunaga M, Orimo H. Kuroda T, et al. Among authors: ohta h. Nihon Rinsho. 2007 Nov 28;65 Suppl 9:271-4. Nihon Rinsho. 2007. PMID: 18161118 Review. Japanese. No abstract available.
Executive summary of the Japan Osteoporosis Society Guide for the Use of Bone Turnover Markers in the Diagnosis and Treatment of Osteoporosis (2018 Edition).
Nishizawa Y, Miura M, Ichimura S, Inaba M, Imanishi Y, Shiraki M, Takada J, Chaki O, Hagino H, Fukunaga M, Fujiwara S, Miki T, Yoshimura N, Ohta H; from the Japan Osteoporosis Society Bone Turnover Marker Investigation Committee. Nishizawa Y, et al. Among authors: ohta h. Clin Chim Acta. 2019 Nov;498:101-107. doi: 10.1016/j.cca.2019.08.012. Epub 2019 Aug 16. Clin Chim Acta. 2019. PMID: 31425674 Free article. Review.
144 results